Keywords: USA, Pulbic-funded reearch, Pricing re-examination, NIS Research, Pfizer, Xeljanz, Senator Wyden

US Senator calls for re-examination of pricing of drugs developed with public funds

Article | 20 March 2013

Print This

US Senator Ron Wyden (Democrat, Oregon) has released a letter written to National Institutes of Health Director Francis Collins regarding ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in